Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Confounding by indication poses a significant threat to the validity of nonexperimental studies assessing effectiveness and safety of medical interventions. While no different from other forms of confounding in theory, confounding by indication often requires specific methods to address the bias it creates in addition to common epidemiological adjustment or restriction methods. Clinical indication influencing treatment prescription is patient‐specific and complex, making it challenging to measure within nonexperimental research. Restriction of the study population to patients with the indication for treatment would effectively mitigate confounding by indication and bring about comparability between exposure and comparator populations with respect to probability of the exposure. Active comparators are often an effective practical solution to restrict the study population in this manner when indication cannot be measured accurately. This article discusses various forms of confounding by indication, the utility of active comparators for nonexperimental studies of treatment effects, and the active comparator, new user (ACNU) study design to implicitly condition on indication. Considerations for selecting active comparators and conducting an ACNU study design are discussed to enable increased adoption of these methods, improve quality of nonexperimental studies, and ultimately strengthen our evidence base for intended and unintended treatment effects in relevant target populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 2×
“Taken together, these components generate the established ACNU study design.(5,16)”
BackgroundLund, J. L., Richardson, D. B., & Stürmer, T. (2015) · Current Epidemiology Reports · doi:10.1007/s40471-015-0053-5 · Cited by 739 · cited 4×
“To do so, we highlight the importance of active comparators to reduce potential for confounding by indication through study design, and present considerations for successful implementation of active comparators and the active comparator, new user (ACNU) study design in pharmacoepidemiology.(5)”
BackgroundInfluentialSelf-citationConfounding by Indication in Clinical Research
Kyriacou, D. N., & Lewis, R. J. (2016) · JAMA · doi:10.1001/jama.2016.16435 · Cited by 565 · cited 1×
“effect estimates will be distorted, often leading to incorrect conclusions, unnecessary or underpowered randomized trials designed based off of biased observational findings, and poor-quality evidence for regulatory and treatment decision-making.(4) By characterizing this pervasive and challenging bias, we aim to fost…”
BackgroundMesser, L. C., Oakes, J. M., & Mason, S. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp435 · Cited by 161
Cited by
Wium‐Andersen, I. K., Wium‐Andersen, M. K., Fink‐Jensen, A., Rungby, J., Jørgensen, M. B., & Osler, M. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13776 · Cited by 93
“We conducted a new-user, active-comparator cohort study using information on the entire Danish population from nationwide registers.(18) The study population was identified in the Danish Civil Registration System using the unique personal identification number (CPR) which enables accurate linkage of recorded individua…”
MethodBaxter, S. M., Lund, L. C., Andersen, J. H., Brix, T. H., Hegedüs, L., Hsieh, M. H.-C., Su, C. T.-T., Cheng, M. C.-Y., Chang, Z. C.-J., Lai, E. C.-C., et al. (2025) · Thyroid® · doi:10.1089/thy.2024.0387 · Cited by 81
Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts
Thompson, C. A., & Stürmer, T. (2023) · Diabetes Care · doi:10.2337/dci22-0052 · Cited by 51
Self-citation
Metadata
- Authors
- Sendor, R., & Stürmer, T.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2022-01-27
- Volume
- 31
- Issue
- 3
- Pages
- 261-269
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W4206319767
- Cited by
- 202
- References
- 5
- FWCI
- 21.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators. https://app.cochat.ai/papers/10.1002/pds.5407
- The paper
- Sendor, R., & Stürmer, T. (2022). Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.